Health Care

2566 posts
Willow Biosciences logo

Willow Biosciences to sell operating subsidiary Epimeron USA Inc.

Willow Biosciences (TSX:WLLW) announced a definitive agreement to sell its wholly-owned operating subsidiary, Epimeron USA Inc.
pharmather logo

PharmaTher receives FDA priority review for ketamine new drug application

PharmaTher (CSE:PHRM) has received a letter from the U.S. Food and Drug Administration (FDA) for its new drug application for ketamine.
Knee osteoarthritis concept

NeuPath Health brings top osteoarthritis treatment to Canada

NeuPath Health (TSXV:NPTH) administers the first injection of Arthrosamid in North America at its Mississauga, Ontario clinic.
ai generated stock image

Buzz on the Bullboards: Stocks making headlines – Baytex, New Found Gold, Theralase

Canada’s main stock index rallied following reports that the US administration was considering relaxing the strict tariffs.
WELL Health clinic

WELL Health benefitting from tariff-based ‘buy Canadian’ sentiment

WELL Health Technologies (TSX:WELL) reports recent momentum thanks to 'buy Canadian' sentiment following Trump's tariffs on Canadian goods.
Covalon Technologies IV Clear dressing

Covalon Technologies earns fourth-straight quarterly profit

Covalon Technologies (TSXV:COV), a medical technology stock, posts a profitable fiscal Q1 2025 ending December 31, 2024.
Genetic cancer medication

Aptose’s leukemia drug cleared to double clinical trial dose

Aptose Biosciences (TSX:APS), a clinical-stage oncology stock, reports dose-escalation approval for tuspetinib, its leukemia drug candidate.
The Market Online Video

Exosome production crucial for regenerative therapy research and development

NurExone Biologic Inc. (TSXV:NRX) has been making significant strides in the field of exosome-based therapies. And...
Woman in MrBeast shirt with Strep A patients in Africa

MrBeast enlists Light AI for Strep A testing in Africa

Light AI (CBOE CA:ALGO), a healthcare technology company focused on diagnostics and wellness, joins forces with top YouTuber MrBeast.
Cancer mutation under target

Aptose Biosciences’ leukemia drug shows early promise

Aptose Biosciences (TSX:APS) achieves positive results from newly diagnosed acute myeloid leukemia patients in its phase 1/2 clinical trial.
labratory work

PharmaTher updates FDA new drug application for Ketamine

PharmaTher Holdings (CSE:PHRM) is on track to resubmit information to the U.S. Food and Drug Administration (FDA) by the end of February.
Medical technician looking into a microscope

Theralase achieves breakthrough Herpes treatment

Clinical-stage pharma stock Theralase Technologies (TSXV:TLT) announced a significant breakthrough in the treatment of Herpes Simplex Viruses (HSV) Independent...
ai generated stock image

Xtract One tech to enhance security at Manitoba hospitals

Xtract One Technologies (TSX:XTRA) has announced that its Gateway has been chosen to secure key hospital locations across Manitoba.
Lung scan before and after BriaCell Therapeutics' Bria OTS cancer treatment

BriaCell immunotherapy destroys metastatic breast cancer tumor

BriaCell (TSX:BCT) reports that the first metastatic breast cancer patient treated with its Bria-OTS drug is now cancer-free in the lungs.
WELL Health founder and CEO Hamed Shahbazi, centre.

WELL Health touts resilience to U.S.-Canada tariffs

WELL Health (TSX:WELL) reported improvements in its acquired clinics' financial performance, supported by its transformation strategy.
Quipt Home Medical location in Corinth, Mississippi

Quipt Home Medical responds to activist investor

Quipt Home Medical (TSX/NASDAQ:QIPT) receives an activist notice intending to solicit proxies for four director candidates to its board.